151 related articles for article (PubMed ID: 18430728)
1. Box 2 region of the oncostatin M receptor determines specificity for recruitment of Janus kinases and STAT5 activation.
Hintzen C; Evers C; Lippok BE; Volkmer R; Heinrich PC; Radtke S; Hermanns HM
J Biol Chem; 2008 Jul; 283(28):19465-77. PubMed ID: 18430728
[TBL] [Abstract][Full Text] [Related]
2. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
3. Signaling of type II oncostatin M receptor.
Auguste P; Guillet C; Fourcin M; Olivier C; Veziers J; Pouplard-Barthelaix A; Gascan H
J Biol Chem; 1997 Jun; 272(25):15760-4. PubMed ID: 9188471
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.
Stross C; Radtke S; Clahsen T; Gerlach C; Volkmer-Engert R; Schaper F; Heinrich PC; Hermanns HM
J Biol Chem; 2006 Mar; 281(13):8458-68. PubMed ID: 16459330
[TBL] [Abstract][Full Text] [Related]
5. Activation of the Jak-Stat- and MAPK-pathways by oncostatin M is not sufficient to cause growth inhibition of human glioma cells.
Halfter H; Postert C; Friedrich M; Ringelstein EB; Stögbauer F
Brain Res Mol Brain Res; 2000 Sep; 80(2):198-206. PubMed ID: 11038252
[TBL] [Abstract][Full Text] [Related]
6. Novel role of Janus kinase 1 in the regulation of oncostatin M receptor surface expression.
Radtke S; Hermanns HM; Haan C; Schmitz-Van De Leur H; Gascan H; Heinrich PC; Behrmann I
J Biol Chem; 2002 Mar; 277(13):11297-305. PubMed ID: 11786531
[TBL] [Abstract][Full Text] [Related]
7. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
[TBL] [Abstract][Full Text] [Related]
8. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H
Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of JAK1/2 Tyrosine Kinases Reduces Neurogenic Heterotopic Ossification After Spinal Cord Injury.
Alexander KA; Tseng HW; Fleming W; Jose B; Salga M; Kulina I; Millard SM; Pettit AR; Genêt F; Levesque JP
Front Immunol; 2019; 10():377. PubMed ID: 30899259
[TBL] [Abstract][Full Text] [Related]
10. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
11. The oncostatin M receptor/gp130 ligand murine oncostatin M induces apoptosis in adrenocortical Y-1 tumor cells.
Auernhammer CJ; Dorn F; Vlotides G; Hengge S; Kopp FB; Spoettl G; Cengic N; Engelhardt D; Weber MM
J Endocrinol; 2004 Mar; 180(3):479-86. PubMed ID: 15012602
[TBL] [Abstract][Full Text] [Related]
12. Analysis of IL-6/gp130 family receptor expression reveals that in contrast to astroglia, microglia lack the oncostatin M receptor and functional responses to oncostatin M.
Hsu MP; Frausto R; Rose-John S; Campbell IL
Glia; 2015 Jan; 63(1):132-41. PubMed ID: 25103368
[TBL] [Abstract][Full Text] [Related]
13. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
14. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the rat oncostatin M receptor complex which resembles the human, but differs from the murine cytokine receptor.
Drechsler J; Grötzinger J; Hermanns HM
PLoS One; 2012; 7(8):e43155. PubMed ID: 22937020
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
Li WQ; Dehnade F; Zafarullah M
J Immunol; 2001 Mar; 166(5):3491-8. PubMed ID: 11207308
[TBL] [Abstract][Full Text] [Related]
17. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M-induced activation of stress-activated MAP kinases depends on tyrosine 861 in the OSM receptor and requires Jak1 but not Src kinases.
Böing I; Stross C; Radtke S; Lippok BE; Heinrich PC; Hermanns HM
Cell Signal; 2006 Jan; 18(1):50-61. PubMed ID: 15935618
[TBL] [Abstract][Full Text] [Related]
19. Differential inhibition of IL-6-type cytokine-induced STAT activation by PMA.
Terstegen L; Maassen BG; Radtke S; Behrmann I; Schaper F; Heinrich PC; Graeve L; Gatsios P
FEBS Lett; 2000 Jul; 478(1-2):100-4. PubMed ID: 10922477
[TBL] [Abstract][Full Text] [Related]
20. Activation of the protein tyrosine phosphatase SHP2 via the interleukin-6 signal transducing receptor protein gp130 requires tyrosine kinase Jak1 and limits acute-phase protein expression.
Schaper F; Gendo C; Eck M; Schmitz J; Grimm C; Anhuf D; Kerr IM; Heinrich PC
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):557-65. PubMed ID: 9794795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
